HSF1 and Alzheimer disease: Taken together, our data from western blots, RTqPCR, and RNAi suggests that treatment with kynurenic acid and carnosine elevates the levels of HSF-1 in a C. elegans model of AD, resulting in transcriptional upregulation and thus increased levels of DNJ-12 and DNJ-19 J-proteins.